leptin receptor deficiency obesity; proopiomelanocortin deficiency obesity

Two Clinical Trials for POMC and LEPR Deficiency Obesity Led to a Significant Reduction in Body Weight and Hunger

Post author:Rose Duesterwald
Post published:November 19, 2020
Post category:Rare Disease

Rhythm Pharmaceuticals, based in Boston, MA, is a biopharmaceutical company focusing on the development of therapies to treat rare genetic diseases that cause obesity. Until now, there have not been…

We believe rare disease patients are people, not a diagnosis. Through education, awareness and some humor, we help patients, caregivers and support persons by providing relevant and often inspirational news and stories.

Our goals are to share stories, cultivate strong community, provide the latest medical findings, connect people and pioneer production of patient worthy information. Help us attain these goals by telling us a little bit about yourself!

Let’s Work Together!

Keep Up to Date

Learn More